Observational studyJournal of cosmetic dermatology2026
Personalized Approach for Acne Management With Dermocosmetics According to Initial Skin Sensitivity.
Observational study in Journal of cosmetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrent acne management relies largely on topical and systemic pharmacotherapy, but these treatments frequently cause cutaneous adverse reactions. Such side effects are of particular concern in patients with initial skin sensitivity, highlighting the need for personalized approaches.
methodsThis 12-week prospective observational study included 308 Korean acne patients to compare the clinical efficacy of a specific dermo-cosmetic (DC) formulation used as monotherapy versus combination therapy in acne patients, and to evaluate a sensitivity-based approach to improve quality of life. Patients were classified into DC monotherapy (n = 151) or combination therapy (n = 157), and to sensitive (n = 144) or non-sensitive (n = 164) subgroups. Primary outcomes were Global Evaluation of Acne (GEA), total lesion count, and sebum secretion levels. Secondary outcomes included skin sensitization score, tolerance assessment, quality of life, and adverse events.
resultsThe DC monotherapy group showed significantly greater improvement in GEA scores, fewer sensitivity symptoms, improved quality of life, and greater tolerability than the combination therapy group (all p < 0.0001). In the sensitive patient subgroup, DC monotherapy was also significantly superior to combination therapy in terms of GEA, tolerability, sensitivity symptoms, and quality of life (all p < 0.0001). In patients without initial sensitivity, improvement in GEA (p = 0.0079), total lesion count (p < 0.0001), and sebum secretion (p < 0.0001) was significantly greater in the combination therapy than in the DC monotherapy.
conclusionThese findings suggest that baseline skin sensitivity may represent an important determinant of treatment selection and support a sensitivity-guided personalized treatment approach in acne management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.